>

School Of Medicine Basic Sciences

  • Vanderbilt University

    Targeting immune suppression to overcome melanoma resistance

    Ann Richmond outlines a promising therapeutic strategy that may re-sensitize treatment-resistant tumors to immunotherapy. The research introduces a three-drug combination that enhances immune activity and suppresses tumor-promoting immune cells. Read More

    Feb. 16, 2026

  • Vanderbilt University

    Nakagawa to deliver inaugural Kairos Lecture on Feb. 26

    Dr. Teru Nakagawa, professor of molecular physiology and biophysics in the School of Medicine Basic Sciences, will deliver the inaugural Kairos Lecture on Thursday, Feb. 26, 2026. Read More

    Feb. 15, 2026

  • Vanderbilt University

    Celebrating love found

    Whether they met at the bench or bonded over research setbacks, these alums prove that meaningful relationships can flourish alongside rigorous scientific training. In honor of Valentine’s Day, we asked them to share how they did it. Read More

    Feb. 12, 2026

  • Vanderbilt University

    Introducing the School of Medicine Basic Sciences Kairos Lecture Series

    The School of Medicine Basic Sciences is launching a new lecture series: “The Kairos Lectures: Research of Consequence at the Right Moment.” Read More

    Feb. 12, 2026

  • Vanderbilt University

    ASPIRE Down the Road: Exploring the local pharmaceutical industry in Nashville

    Vanderbilt trainees and postdocs explored Nashville’s biotech scene, starting with contract research organization Inotiv. Read More

    Feb. 10, 2026

  • Semaglutide injection with yellow background

    Prolonged semaglutide treatment reveals distinct stages of weight loss, maintenance, and regain

    In a new study published in Diabetes, researchers found that prolonged treatment with the GLP-1R agonist semaglutide led to changes in feeding habits and fuel use in an animal model, offering new insights into the behavioral and metabolic adaptations that accompany weight loss, weight maintenance, and rapid weight regain after stopping treatment. Read More

    Feb. 10, 2026

  • Vanderbilt University

    School of Medicine Basic Sciences Staff Spotlight: Prashant Singh

    Meet Prashant Singh, senior research associate in the Tina Iverson lab within the School of Medicine Basic Sciences. Read More

    Feb. 6, 2026

  • Stylized microscopy image showing a matrix of holes in green on the left and magenta on the right.

    Aging researchers find new puzzle piece in the game of longevity

    The lab of Kris Burkewitz just made a key discovery: How cellular machineries are structured and organized within a cell has implications for healthy aging. “We didn't just add a piece to the puzzle—we found a whole section that hasn't even been touched,” Eric Donahue, first author of the study, said. Read More

    Feb. 2, 2026

  • Kidney Disease Research

    Kidney Disease Research

    Kidney Disease Vanderbilt School of Medicine’s Basic Sciences investigators study kidney cancer and kidney disease from molecules to patients. Teams link genomics, epigenetics, and metabolism to clear cell renal cell carcinoma initiation, therapy resistance, and tumor-immune microenvironment. Researchers build organoid, CRISPR, and mouse models to test pathways and identify drug… Read More

    Jan. 29, 2026

  • Gallbladder Disease Research

    Gallbladder Disease Research

    Gallbladder Disease Research Vanderbilt School of Medicine’s Basic Sciences researchers study gallbladder disease by probing the fundamental biology behind gallstone formation and biliary inflammation. Work commonly integrates cell and animal models with human biospecimens. Investigators explore genetic and environmental risk factors, including diet and the gut-liver-biliary axis, and apply modern… Read More

    Jan. 29, 2026